Vancouver Biotech (Canada)
In research, Vancouver Biotech (Canada) stands highest in Health Sciences (#3,476 of 16,688 worldwide), Medicine (#3,454 of 14,558 worldwide) and Social Sciences (#4,201 of 14,833 worldwide), over all time.
- World rank, 2022-now
- #21,438 of 22,385 · #3,439 all time
- Rank in Canada
- #297 of 305
- Research works
- 499 ▼ 22% vs 2018-21
- Citations
- 7.7k 15.4 per fractional work
- Top-10% rate
- 13.0% all institutions 10.0%
- vs its own fields
- 0.92× 1.00× is exactly expected
- Open access
- 49% world 40%
- International
- 17% world 18%
What is Vancouver Biotech (Canada) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Health SciencesDomain | #3,476 of 16,688 | 8.3% | 191 | |
| MedicineField | #3,454 of 14,558 | 8.7% | 165 | |
| Social SciencesDomain | #4,201 of 14,833 | 11.2% | 121 |
Each strip is that field's whole ranked pool, with the notch where Vancouver Biotech (Canada) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).
Which fields of science does Vancouver Biotech (Canada) work in?
In 2022-now, 67% of research at Vancouver Biotech (Canada) is in Health Sciences, 23% in Life Sciences. Its largest fields are Medicine (64%), Biochemistry, Genetics and Molecular Biology (16%), Immunology and Microbiology (4%). It does 2.7× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 16 fields, with their numbers
- Health Sciences6267.1%
- Medicine6064.3%
- Health Professions32.7%
- Life Sciences2122.8%
- Social Sciences66.9%
- Physical Sciences33.3%
- Engineering11.4%
- Computer Science10.7%
- Environmental Science10.7%
- Materials Science00.3%
- Earth and Planetary Sciences00.1%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 3.7×. Every wedge is a field page.
All 16 fields, with their numbers
- Immunology and Microbiology3.71×4 works
- Medicine3.35×60 works
- Biochemistry, Genetics and Molecular Biology2.94×15 works
- Health Professions1.04×3 works
- Pharmacology, Toxicology and Pharmaceutics1.02×0 works
- Neuroscience0.86×1 works
- Economics, Econometrics and Finance0.59×1 works
- Business, Management and Accounting0.56×2 works
- Psychology0.38×1 works
- Agricultural and Biological Sciences0.34×2 works
- Social Sciences0.21×2 works
- Environmental Science0.14×1 works
- Engineering0.10×1 works
- Computer Science0.09×1 works
- Materials Science0.09×0 works
- Earth and Planetary Sciences0.06×0 works
- Immunology and Microbiology 3.7×
- Medicine 3.4×
- Biochemistry, Genetics and Molecular Biology 2.9×
- Health Professions 1.0×
- Pharmacology, Toxicology and Pharmaceutics 1.0×
- Neuroscience 0.9×
- Economics, Econometrics and Finance 0.6×
- Business, Management and Accounting 0.6×
- Psychology 0.4×
- Agricultural and Biological Sciences 0.3×
- Social Sciences 0.2×
- Environmental Science 0.1×
- Engineering 0.1×
- Computer Science 0.1×
- Materials Science 0.1×
- Earth and Planetary Sciences 0.1×
Who are the top researchers at Vancouver Biotech (Canada)?
Ranked on the quality score, Ronghua Zhao, Jun Ding and Yanal M. Murad lead among researchers whose main affiliation is Vancouver Biotech (Canada).
- 1
Ronghua Zhao
Canada · #804,893 worldwide 1.3k citations · 49 works
- 2
Jun Ding
Canada · #1,072,741 worldwide 274 citations · 25 works
- 3
Yanal M. Murad
Canada · #1,479,266 worldwide 897 citations · 38 works
- 4
Kay Cahill
Canada · #1,691,075 worldwide 134 citations · 15 works
- 5
S. Mack Eastman
Canada · #1,775,240 worldwide 179 citations · 69 works
- 6
Robin McKie
Canada · #4,151,762 worldwide 55 citations · 21 works
- 7
William E. Fredeman
Canada · #4,318,455 worldwide 70 citations · 52 works
- 8
Heather Kent
Canada · #5,376,201 worldwide 813 citations · 122 works
- 9
D. Gray-Grant
Canada · #5,873,130 worldwide 34 citations · 46 works
Which keywords describe research at Vancouver Biotech (Canada)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Immunotherapy, Epidemiology, Genetic Mutations, Gene Therapy, Radiotherapy, Radiosurgery, Prognosis and Surgical Management.
- Cognitive Impairment
- Tumor Suppressor
- Guideline Development
- Quality Assessment
- Epilepsy
- Diagnostic Criteria
- Glioblastoma
- Molecular Classification
- Tumor Regression
- Pathogenesis
- Viral Vectors
- Meningiomas
- AAV
- Treatment
- Inflammation
- Neurological Disorders
- Surgical Management
- Radiosurgery
- Gene Therapy
- Immunotherapy
- Epidemiology
- Genetic Mutations
- Radiotherapy
- Prognosis
- Public Health
- Prognostic Factors
- Autoantibodies
- Genomic Analysis
- Histological Classification
- Vaccine
- Clinical Trials
- Immune Response
- Clinical Management
- Neuroprotection
- Temozolomide
- Endovascular Treatment
- Intravenous Immunoglobulin
- Clinical Guidelines
- Neurofibromatosis
- Antiepileptic Drugs
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology13▲ 3.4×24 topics
- Immunotherapy9▲ 14×8 topics
- Genetic Mutations7▲ 16×7 topics
- Gene Therapy6▲ 33×3 topics
- Radiotherapy6▲ 16×5 topics
- Radiosurgery5▲ 63×3 topics
- Prognosis5▲ 17×5 topics
- Surgical Management5▲ 13×5 topics
- Public Health5▲ 3.7×9 topics
- Neurological Disorders5▲ 9.1×8 topics
- Prognostic Factors4▲ 11×2 topics
- Inflammation4▲ 2.0×9 topics
- Autoantibodies4▲ 17×5 topics
- Treatment4▲ 3.2×9 topics
- Genomic Analysis4▲ 15×2 topics
- AAV3▲ 87×1 topic
- Histological Classification3▲ 113×1 topic
- Meningiomas3▲ 113×1 topic
- Vaccine3▲ 8.6×5 topics
- Viral Vectors3▲ 87×1 topic
- Clinical Trials3▲ 4.8×7 topics
- Pathogenesis3▲ 6.2×4 topics
- Immune Response3▲ 5.2×4 topics
- Tumor Regression3▲ 27×2 topics
- Clinical Management3▲ 16×4 topics
- Molecular Classification3▲ 18×2 topics
- Neuroprotection3▲ 7.9×3 topics
- Glioblastoma2▲ 39×1 topic
- Temozolomide2▲ 39×1 topic
- Diagnostic Criteria2▲ 11×4 topics
- Endovascular Treatment2▲ 41×2 topics
- Epilepsy2▲ 21×2 topics
- Intravenous Immunoglobulin2▲ 37×2 topics
- Quality Assessment2▲ 13×2 topics
- Clinical Guidelines2▲ 7.8×1 topic
- Guideline Development2▲ 118×1 topic
- Neurofibromatosis2▲ 115×1 topic
- Tumor Suppressor2▲ 54×1 topic
- Antiepileptic Drugs2▲ 28×2 topics
- Cognitive Impairment2▲ 8.5×4 topics
Which research topics does Vancouver Biotech (Canada) publish most on?
By volume in 2022-now: Meningioma and schwannoma management, Virus-based gene therapy research, Glioma Diagnosis and Treatment and Neurofibromatosis and Schwannoma Cases.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Meningioma and schwannoma management Epidemiology 3 works
- 2 Virus-based gene therapy research Genetics 3 works
- 3 Glioma Diagnosis and Treatment Genetics 2 works
- 4 Neurofibromatosis and Schwannoma Cases Neurology 2 works
- 5 Clinical practice guidelines implementation Public Health, Environmental and Occupational Health 2 works
- 6 Epilepsy research and treatment Psychiatry and Mental health 2 works
- 7 Cancer Research and Treatments Biotechnology 2 works
- 8 Vascular Malformations Diagnosis and Treatment Neurology 2 works
- 9 Peripheral Neuropathies and Disorders Neurology 2 works
- 10 Trauma and Emergency Care Studies Emergency Medicine 2 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Vancouver Biotech (Canada)'s research output changed?
Output in 2022-2025 was 22% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Vancouver Biotech (Canada) as a percentage of every work published that year, 0.00054% in 2024.
Fractional works of Vancouver Biotech (Canada) over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year, against all institutions in the same year.
Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 13.0% in 2025.
Other research institutions in Vancouver
- University of British Columbia
- TRIUMF
- Vancouver Coastal Health
- Columbia College
- Provincial Health Services Authority
- Quest University Canada
- Providence Health Care
- Children's & Women's Health Centre of British Columbia
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Vancouver Biotech (Canada). Posts are plain text and can be reported.
